Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 13Terminated 3Recruiting 3Active not recruiting 2Unknown 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 16Gastrointestinal 2Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1CNS 1Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 65Lymphoma 59Lymphoma, Follicular 53Lymphoma, Large B-Cell, Diffuse 51Lymphoma, B-Cell 50Leukemia, Lymphocytic, Chronic, B-Cell 34Lymphoma, Non-Hodgkin 33Recurrence 27Leukemia 22Lymphoma, Mantle-Cell 20Burkitt Lymphoma 18Lymphoma, T-Cell, Peripheral 17Leukemia, Myeloid, Acute 15Hodgkin Disease 15Waldenstrom Macroglobulinemia 14Hematologic Neoplasms 14Lymphoma, B-Cell, Marginal Zone 13Multiple Myeloma 12Lymphoma, T-Cell, Cutaneous 12Lymphoma, Extranodal NK-T-Cell 12Neoplasms 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, B-Cell 8Motor Activity 7Myelodysplastic Syndromes 6Mycosis Fungoides 6Sezary Syndrome 5Neoplasm, Residual 5Pain 4Neoplasms, Plasma Cell 4

Interventions

Sirolimus 1Prednisone 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Skin Neoplasms × Lymphoid × Clear all
NCT07426484 2026-02-23

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

Dana-Farber Cancer Institute

Phase 4 Not yet recruiting
80 enrolled
DermatologicLymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Waldenstrom Macroglobulinemia, Skin Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡